About Amillex
Company Overview
Amillex is an Australian-registered multi-asset brokerage founded in July 2024. The company operates from its registered address in Sydney, Australia, and claims regulation by the Financial Services Commission (FSC) of Mauritius and the Australian Securities and Investments Commission (ASIC). However, independent verification of these licences is recommended due to the limited public information available.
Regulation
Amillex states it is regulated by two bodies: the FSC (Mauritius) with a Securities Trading License, and ASIC (Australia) for Inst Forex Execution (STP). Traders should note that ASIC regulation typically imposes stricter leverage limits, but the broker offers leverage up to 1:500, which is unusual for an ASIC-licensed entity. Cross-checking with official registers is advised to confirm the validity and scope of these licences.
Account Types
The broker offers three account tiers: CENT, STANDARD, and RAW. All require a minimum deposit of $50 and allow maximum leverage of 1:500. The differences between these accounts likely relate to spreads and commission structures, but specific details are not publicly disclosed. The CENT account may be suitable for micro-lot trading, while RAW might appeal to more experienced traders seeking raw spreads.
Trading Instruments
Amillex describes itself as a multi-asset platform, enabling investment in stock indices, digital assets, and CFD trading. The full list of available instruments is not publicly detailed, which limits transparency for potential traders. The absence of a comprehensive instrument list means traders cannot fully assess the breadth of offerings.
Target Audience
With a low minimum deposit of $50 and high leverage options up to 1:500, Amillex appears to target retail traders, including beginners. The CENT account suggests support for micro-lot trading, which could attract new traders. However, the lack of independent reviews and limited public information warrants caution for those considering this broker.
Overview compiled by FXCanary from regulatory records and public data. full Amillex review